Defining a Safe Biopsy Deferral Strategy in Patients With Low-Risk or Equivocal MRI Findings Using Prostate-Specific Antigen-Based Metrics.
This prospective single-center study examined whether prostate-specific antigen (PSA)-based measures could identify a low-risk subgroup suitable for biopsy deferral in patients with Prostate Imaging-Reporting and Data System (PI-RADS) 1-3 lesions, and which clinical & imaging factors further refined risk stratification...